Stock AnalizThermo Fisher Scientific (TMO) earnings for the quarter ended September 2026: EPS beats estimates
Thermo Fisher Scientific reported results for the quarter ended September 2026 on October 21, 2026. Adjusted earnings per share came in at $6.68 against the analysts’ average forecast of $6.40, a beat of 4.3%.
Revenue for the quarter was $12.14 billion, up 9.1% from $11.12 billion in the same quarter a year earlier.
The market’s verdict: the stock rose 1.0% on the first trading day after the report.
The last four quarters
Thermo Fisher Scientific has beaten the analysts’ EPS forecast in 4 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $6.68 | $6.40 | +4.3% | +9% | +1.0% |
| Jun 2026 | $6.03 | $5.71 | +5.5% | +10% | +7.9% |
| Mar 2026 | $5.44 | $5.24 | +3.8% | +6% | −8.6% |
| Dec 2025 | $6.57 | $6.45 | +1.9% | +7% | −4.8% |
What comes next
Analysts expect EPS of $7.13 for the next quarter on average and $25.28 for the fiscal year ending December 31, 2026.
The average analyst price target is $756.52, 8% above the current price of $700.22.
Valuation and score
Thermo Fisher Scientific scores 2.0 out of 5 overall on Stock Analiz (average), trades at a trailing P/E of about 36.9, and its intrinsic value under moderate assumptions is about 51% below the current market value. Full Thermo Fisher Scientific analysis with 10 years of financials
Frequently asked questions
What was Thermo Fisher Scientific’s EPS for the quarter ended September 2026?
$6.68 adjusted per share, against an analyst consensus of $6.40.
How much revenue did Thermo Fisher Scientific report?
$12.14 billion, up 9.1% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.